The Role of Pericytes in Inner Ear Disorders: A Comprehensive Review
- PMID: 39452111
- PMCID: PMC11504721
- DOI: 10.3390/biology13100802
The Role of Pericytes in Inner Ear Disorders: A Comprehensive Review
Abstract
Inner ear disorders, including sensorineural hearing loss, Meniere's disease, and vestibular neuritis, are prevalent conditions that significantly impact the quality of life. Despite their high incidence, the underlying pathophysiology of these disorders remains elusive, and current treatment options are often inadequate. Emerging evidence suggests that pericytes, a type of vascular mural cell specialized to maintain the integrity and function of the microvasculature, may play a crucial role in the development and progression of inner ear disorders. The pericytes are present in the microvasculature of both the cochlea and the vestibular system, where they regulate blood flow, maintain the blood-labyrinth barrier, facilitate angiogenesis, and provide trophic support to neurons. Understanding their role in inner ear disorders may provide valuable insights into the pathophysiology of these conditions and lead to the development of novel diagnostic and therapeutic strategies, improving the standard of living. This comprehensive review aims to provide a detailed overview of the role of pericytes in inner ear disorders, highlighting the anatomy and physiology in the microvasculature, and analyzing the mechanisms that contribute to the development of the disorders. Furthermore, we explore the potential pericyte-targeted therapies, including antioxidant, anti-inflammatory, and angiogenic approaches, as well as gene therapy strategies.
Keywords: inner ear; pathophysiology; pericyte-target therapy; pericytes; sensorineural hearing loss.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Investigations of the Microvasculature of the Human Macula Utricle in Meniere's Disease.Front Cell Neurosci. 2019 Oct 4;13:445. doi: 10.3389/fncel.2019.00445. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31636542 Free PMC article.
-
VEGFA165 gene therapy ameliorates blood-labyrinth barrier breakdown and hearing loss.JCI Insight. 2021 Apr 22;6(8):e143285. doi: 10.1172/jci.insight.143285. JCI Insight. 2021. PMID: 33690221 Free PMC article.
-
Blood-Labyrinth Barrier in Health and Diseases: Effect of Hormetic Nutrients.Antioxid Redox Signal. 2024 Mar;40(7-9):542-563. doi: 10.1089/ars.2023.0251. Epub 2023 Oct 25. Antioxid Redox Signal. 2024. PMID: 37565276 Review.
-
Research advances in cochlear pericytes and hearing loss.Hear Res. 2023 Oct;438:108877. doi: 10.1016/j.heares.2023.108877. Epub 2023 Aug 19. Hear Res. 2023. PMID: 37651921 Free PMC article. Review.
-
Inner ear disorders.NeuroRehabilitation. 2013;32(3):455-62. doi: 10.3233/NRE-130868. NeuroRehabilitation. 2013. PMID: 23648600 Review.
References
-
- Young A.S., Rosengren S.M., Welgampola M.S. Chapter 25—Disorders of the Inner-Ear Balance Organs and Their Pathways. In: Day B.L., Lord S.R., editors. Handbook of Clinical Neurology. Volume 159. Elsevier; Amsterdam, The Netherlands: 2018. pp. 385–401. - PubMed
-
- Azaiez H., Booth K.T., Ephraim S.S., Crone B., Black-Ziegelbein E.A., Marini R.J., Shearer A.E., Sloan-Heggen C.M., Kolbe D., Casavant T., et al. Genomic Landscape and Mutational Signatures of Deafness-Associated Genes. Am. J. Hum. Genet. 2018;103:484–497. doi: 10.1016/j.ajhg.2018.08.006. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources